tetano
Editor, Senior Moderator
JCI Insight
. 2024 Jan 16:e170316.
doi: 10.1172/jci.insight.170316. Online ahead of print. Myeloid Zfhx3 deficiency protects against hypercapnia-induced suppression of host defense against influenza A virus
S Marina Casalino-Matsuda[SUP] 1 [/SUP], Fei Chen[SUP] 1 [/SUP], Francisco J Gonzalez-Gonzalez[SUP] 1 [/SUP], Hiroaki Matsuda[SUP] 2 [/SUP], Aisha Nair[SUP] 1 [/SUP], Hiam Abdala-Valencia[SUP] 1 [/SUP], G R Scott Budinger[SUP] 1 [/SUP], Jin-Tang Dong[SUP] 3 [/SUP], Greg J Beitel[SUP] 4 [/SUP], Peter Hs Sporn[SUP] 1 [/SUP]
Affiliations
Hypercapnia, elevation of the partial pressure of CO2 in blood and tissues, is a risk factor for mortality in patients with severe acute and chronic lung diseases. We previously showed that hypercapnia inhibits multiple macrophage and neutrophil antimicrobial functions, and that elevated CO2 increases the mortality of bacterial and viral pneumonia in mice. Here, we show that normoxic hypercapnia downregulates innate immune and antiviral gene programs in alveolar macrophages (AMØs). We also show that zinc finger homeobox 3 (Zfhx3), a mammalian ortholog of zfh2, which mediates hypercapnic immune suppression in Drosophila, is expressed in mouse and human macrophages. Deletion of Zfhx3 in the myeloid lineage blocked the suppressive effect of hypercapnia on immune gene expression in AMØs and decreased viral replication, inflammatory lung injury and mortality in hypercapnic mice infected with influenza A virus. Our results establish Zfhx3 as the first known mammalian mediator of CO2 effects on immune gene expression and lay the basis for future studies to identify therapeutic targets to interrupt hypercapnic immunosuppression in patients with advanced lung disease.
Keywords: Immunology; Influenza; Innate immunity; Macrophages; Pulmonology.
. 2024 Jan 16:e170316.
doi: 10.1172/jci.insight.170316. Online ahead of print. Myeloid Zfhx3 deficiency protects against hypercapnia-induced suppression of host defense against influenza A virus
S Marina Casalino-Matsuda[SUP] 1 [/SUP], Fei Chen[SUP] 1 [/SUP], Francisco J Gonzalez-Gonzalez[SUP] 1 [/SUP], Hiroaki Matsuda[SUP] 2 [/SUP], Aisha Nair[SUP] 1 [/SUP], Hiam Abdala-Valencia[SUP] 1 [/SUP], G R Scott Budinger[SUP] 1 [/SUP], Jin-Tang Dong[SUP] 3 [/SUP], Greg J Beitel[SUP] 4 [/SUP], Peter Hs Sporn[SUP] 1 [/SUP]
Affiliations
- PMID: 38227369
- DOI: 10.1172/jci.insight.170316
Hypercapnia, elevation of the partial pressure of CO2 in blood and tissues, is a risk factor for mortality in patients with severe acute and chronic lung diseases. We previously showed that hypercapnia inhibits multiple macrophage and neutrophil antimicrobial functions, and that elevated CO2 increases the mortality of bacterial and viral pneumonia in mice. Here, we show that normoxic hypercapnia downregulates innate immune and antiviral gene programs in alveolar macrophages (AMØs). We also show that zinc finger homeobox 3 (Zfhx3), a mammalian ortholog of zfh2, which mediates hypercapnic immune suppression in Drosophila, is expressed in mouse and human macrophages. Deletion of Zfhx3 in the myeloid lineage blocked the suppressive effect of hypercapnia on immune gene expression in AMØs and decreased viral replication, inflammatory lung injury and mortality in hypercapnic mice infected with influenza A virus. Our results establish Zfhx3 as the first known mammalian mediator of CO2 effects on immune gene expression and lay the basis for future studies to identify therapeutic targets to interrupt hypercapnic immunosuppression in patients with advanced lung disease.
Keywords: Immunology; Influenza; Innate immunity; Macrophages; Pulmonology.